Assertio Therapeutics, Inc.
Data ndekọ gọọmentị
0ndị na-eso
2018tọrọ ntọala
Maka Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Isi ụlọ ọrụ251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Tọrọ ntọala2018
ỌnọdụNa-arụ ọrụ
Patent1 patent
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Nyocha
Enweghị nyocha ugbu a. Ị rụrụ ọrụ na Assertio Therapeutics, Inc.? Bụrụ onye mbụ kekọrịta ahụmahụ gị.
Ozi iwu
| Aha iwu | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Lee na GLEIF ↗ |
| Adreesị edebanyere aha | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Ọnọdụ | Na-arụ ọrụ |
Isi mmalite: GLEIF · emelitere 16 Ọktoba 2026
Kọntaktị & njikọ
Ebe
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Nke a ọ bụ ụlọ ọrụ gị?
Kwuo ibe a n'efu iji tinye logo gị, ngwaahịa, foto na ọrụ, na iza nyocha.
Kwuo ibe aSonye na Heelky iji jikọọ, were ndị ọrụ ma too
Mepụta akaụntụ efu iji zipụ ndị mmadụ ozi, tinye arịrịọ ọrụ ma bipụta mishọn.
Sonye ugbu a — ọ bụ n'efu